Actively Recruiting

Age: 55Years - 75Years
All Genders
Healthy Volunteers
NCT05020106

The Diagnostic Cut-off Value of Core Biomarkers of Alzheimer's Disease

Led by Capital Medical University · Updated on 2026-03-23

3200

Participants Needed

1

Research Sites

469 weeks

Total Duration

On this page

Sponsors

C

Capital Medical University

Lead Sponsor

S

Shandong Provincial Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

The participant in this study includes Alzheimer's disease (AD including familial AD and sporadic AD) patients, amnestic mild cognitive impairment (aMCI) patients, non-AD dementia patients and cognitively normal control. The purpose of this study is to establish the best cut-off value of cerebrospinal fluid (CSF) and blood β-amyloid (Aβ) 42/40, total tau (t-tau) , phosphorylated tau ,inflammatory factors, etc. in diagnosis of Alzheimer's disease (AD).

CONDITIONS

Official Title

The Diagnostic Cut-off Value of Core Biomarkers of Alzheimer's Disease

Who Can Participate

Age: 55Years - 75Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Aged 55 to 75 years
  • Written informed consent obtained from participant or legal guardian before any study procedures
  • Diagnosis of Alzheimer's disease using NIA-AA criteria
  • Diagnosis of amnestic mild cognitive impairment by 2004 Petersen criteria
  • Diagnosis of non-Alzheimer's dementia by established criteria (McKeith for DLB, bvFTD Consortium for behavioral variant FTD, Gorno-Tempini for semantic variant FTD or non-fluent aphasia, Movement Disorder Society for PDD, Vas-Cog for VaD, Armstrong's for CBD, CDC for CJD)
  • Normal cognition supported by MMSE, CDR, and other cognitive function scales
Not Eligible

You will not qualify if you...

  • Presence of other medical or psychiatric illnesses
  • No available informant
  • Refusal to complete cognitive tests or provide biological specimens

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Xuanwu Hospital of Capital Medical University

Beijing, Beijing Municipality, China, 100053

Actively Recruiting

Loading map...

Research Team

J

Jianping Jia, Doctor

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

The Diagnostic Cut-off Value of Core Biomarkers of Alzheimer's Disease | DecenTrialz